enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Rivaroxaban - Wikipedia

   en.wikipedia.org/wiki/Rivaroxaban

   Rivaroxaban, sold under the brand name Xarelto among others, is an anticoagulant medication (blood thinner) used to treat and prevent blood clots. [8] Specifically it is used to treat deep vein thrombosis and pulmonary emboli and prevent blood clots in atrial fibrillation and following hip or knee surgery. [ 8 ]

3. Prevention of type 2 diabetes - Wikipedia

   en.wikipedia.org/wiki/Prevention_of_type_2_diabetes

   Prevention of type 2 diabetes can be achieved with both lifestyle changes and use of medication. [1] The American Diabetes Association categorizes people with prediabetes , who have glycemic levels higher than normal but do not meet criteria for diabetes, as a high-risk group.

4. What Is Diabetes: Risk Factors & Treatment - AOL

   www.aol.com/diabetes-risk-factors-treatment...

   Diabetes is very common. The Centers for Disease Control and Prevention (CDC) notes that 38.4 million people in the United States are currently living with diabetes. That’s 11.6 percent of the ...

5. Medication package insert - Wikipedia

   en.wikipedia.org/wiki/Medication_package_insert

   Warnings - covers possible serious side effects that may occur (e.g., boxed warning) Precautions - explains how to use the medication safely including physical impairments, food (grapefruits) and drug interactions; for example "Do not drink alcohol while taking this medication" or "Do not take this medication if you are currently taking MAOI ...

6. Diabetes management - Wikipedia

   en.wikipedia.org/wiki/Diabetes_management

   The main goal of diabetes management is to keep blood glucose (BG) levels as normal as possible. [1] If diabetes is not well controlled, further challenges to health may occur. [1] People with diabetes can measure blood sugar by various methods, such as with a BG meter or a continuous glucose monitor, which monitors over several days. [2]

7. In weight loss battle, Novo and Lilly face growing offensive ...

   www.aol.com/news/weight-loss-battle-novo-lilly...

   SHANGHAI (Reuters) - As Novo Nordisk and Eli Lilly expand sales of their popular diabetes and weight-loss drugs, cheaper copies of their patented remedies are winning approval from some regulators ...